Axitinib Metabolite G |
|
| Synonyms: Axitinib Lactose Adduct;2-((1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)-3-((E)-2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)-N-methylbenzamide | |
| Cat. No.: A86036 | CAS No.: N.A. |
| MDL.: | Formula: C34H38N4O11S |
| F.W.710.75 | Purity: 99 |
| Storage: | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | $205.00 | Enter qty and click checkbox |
 
|
$205.00 |
| Catalog Number： | A86036 | CAS No.: | N.A. | |
| MDL: | Formula: | C34H38N4O11S | ||
| F.W.: | 710.75 | Purity: | 99 | |
| Package: | Unit: | |||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Category: | Reference Standard | ||
| Reference: | Wasser, K., et al.: Eur. Radiol., 13, 80 (2003), Park, J., et al.: Clin. Cancer Res., 8, 1172 (2002), Bergers, G., et al.: J. Clin. Invest., 111, 1287 (2003), | |||
| Application: | Axitinib Lactose Adduct is a possible metabolite of Axitinib, a tyrosine kinase inhibitor. Axitinib is used in cancer therapy. | |||
| Category: | Aromatics, Metabolites, Pharmaceuticals, Intermediates & Fine Chemicals, Tyrosine Kinase Inhibitors, | |||